11/14/2024
11:15 AM | Kynam Capital Management, LP (Filed by)
Vera Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
8:35 AM | Avoro Capital Advisors LLC (Filed by)
Vera Therapeutics (Subject)
| Form SC 13G | |
11/12/2024
9:34 AM | FMR LLC (Filed by)
Vera Therapeutics (Subject)
| Form SC 13G/A | |
11/07/2024
7:00 AM | Vera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
6:49 PM | Longitude Capital Partners IV, LLC (Filed by)
Vera Therapeutics (Subject)
| Form SC 13D/A | |
10/31/2024
5:05 AM | Vera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2024
3:15 PM | Vera Therapeutics (Filer)
| Form 424B5 | |
|
10/29/2024
5:15 AM | Vera Therapeutics (Filer)
| Form 424B5 | |
10/28/2024
4:29 PM | Vera Therapeutics (Filer)
| Form S-3ASR | |
10/28/2024
4:30 PM | Vera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/28/2024
3:37 PM | SEIDENBERG BETH C (Reporting)
Vera Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/23/2024
3:16 PM | Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/11/2024
3:05 PM | Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/09/2024
3:17 PM | Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2024
8:01 AM | Vera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2024
3:05 PM | Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2024
3:45 PM | SEIDENBERG BETH C (Reporting)
Vera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
3:38 PM | SEIDENBERG BETH C (Reporting)
Vera Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
3:38 PM | SEIDENBERG BETH C (Reporting)
Vera Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2024
3:36 PM | Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
3:19 PM | Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/30/2024
3:04 PM | Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2024
4:40 PM | Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
3:31 PM | Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
3:24 PM | Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/08/2024
3:36 PM | Vera Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024
7:00 AM | Vera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/17/2024
4:15 PM | Vera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
6:30 AM | Vera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/05/2024
8:27 PM | Grant Sean (Reporting)
Vera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/05/2024
8:32 PM | Grant Sean (Reporting)
Vera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
8:55 PM | Vera Therapeutics (Filer)
| Form ARS | |
04/03/2024
4:00 PM | Vera Therapeutics (Filer)
| Form DEF 14A | |
04/03/2024
4:02 PM | Vera Therapeutics (Filer)
| Form DEFA14A | |
03/26/2024
7:35 PM | Vera Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/26/2024
6:57 PM | Sofinnova Venture Partners X, L.P. (Filed by)
Vera Therapeutics (Subject)
| Form SC 13D/A | |
03/25/2024
8:46 PM | Katabi Maha (Reporting)
Vera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
3:54 PM | Katabi Maha (Reporting)
Vera Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024
6:30 AM | Vera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2024
6:11 PM | Sofinnova Venture Partners X, L.P. (Filed by)
Vera Therapeutics (Subject)
| Form SC 13D/A | |
02/14/2024
3:57 PM | CITADEL ADVISORS LLC (Filed by)
Vera Therapeutics (Subject)
| Form SC 13G/A | |
Breaking News: Tesla headed to $500… (Ad) That headline hit late last night…and the rally has begun
Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla.  So to claim your free digital copy today, simply follow this link and enter your email address. |
02/14/2024
2:21 PM | Ares Trading S.A. (Filed by)
Vera Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
11:49 AM | Kynam Capital Management, LP (Filed by)
Vera Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
9:05 AM | FMR LLC (Filed by)
Vera Therapeutics (Subject)
| Form SC 13G/A | |
02/05/2024
3:45 PM | Longitude Capital Partners IV, LLC (Filed by)
Vera Therapeutics (Subject)
| Form SC 13D/A | |
02/01/2024
4:58 PM | Katabi Maha (Reporting)
Vera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
3:52 PM | Vera Therapeutics (Filer)
| Form 424B5 | |
01/30/2024
3:54 PM | Vera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/29/2024
8:58 PM | Vera Therapeutics (Filer)
| Form S-3MEF | |
01/29/2024
4:25 PM | BlackRock Inc. (Filed by)
Vera Therapeutics (Subject)
| Form SC 13G | |
01/29/2024
3:27 PM | Lin Celia (Reporting)
Vera Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2024
7:46 AM | Vera Therapeutics (Filer)
| Form 424B5 | |
01/29/2024
5:05 AM | Vera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/25/2024
5:31 AM | Vera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/18/2024
3:54 PM | Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/12/2024
8:55 PM | COMMODORE CAPITAL LP (Reporting)
Vera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
7:17 AM | Brenner Robert (Reporting)
Vera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
7:03 AM | Vera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
7:05 AM | Vera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
7:15 AM | Brenner Robert (Reporting)
Vera Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/03/2024
3:15 PM | Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
